Milka Elena Martinez Arache, M.D Internal Medicine Medicare: May Accept Medicare Assignments Practice Location: 47344 Us Highway 78, Lincoln, AL 35096 Phone: 205-763-7848 |
News Archive
Eli Lilly and Company and Avid Radiopharmaceuticals, Inc., a wholly owned subsidiary of Lilly, today announced the U.S. Food and Drug Administration (FDA) approval of Amyvid, a radioactive diagnostic agent indicated for brain imaging of beta-amyloid plaques in patients with cognitive impairment who are being evaluated for Alzheimer's Disease and other causes of cognitive decline.
Having a lower body-mass index, but also with having a higher waist-to-height ratio, is associated with worse outcomes among Asian patients with heart failure, according to a study published September 24 in the open-access journal PLOS Medicine by Carolyn Lam of the National Heart Centre Singapore, and colleagues.
In its recently released annual 2010 update, ChartTrends®: Biologics in Rheumatoid Arthritis, BioTrends Research Group, Inc. finds that newer biologic agents such as UCB's Cimzia and Centocor OrthoBiotech's Simponi, although lagging in overall market share, have begun to penetrate the first line biologic position primarily at the expense of Pfizer/Amgen's Enbrel and Abbott's Humira.
The Academy of Medical Sciences is delighted to announce a pledge of £600,000 from the Dennis and Mireille Gillings Foundation towards a pilot programme to develop two cohorts of innovative new leaders in medical science.
A team of researchers from UCSF and UC San Diego has identified an approved arthritis drug that is effective against amoebas in lab and animal studies, suggesting it could offer a low-dose, low cost treatment for the amoebic infections that cause human dysentery throughout the world.
› Verified 3 days ago